PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Doxycycline Hyclate Tablets | 75mg |
 |
60 |
68180-654-07 |
Acticlate |
AB |
Tetracycline Antibiotics |
| Doxycycline Monohydrate Capsules USP | 50mg |
 |
50 |
68180-652-08 |
Monodox® |
AB |
Anti-Infectives |
| Drospirenone & Ethinyl Estradiol Tablets USP | 3mg/0.03mg |
|
28 x 3 |
68180-0868-73 |
Yasmin® |
AB |
Oral Contraceptives |
| Drospirenone, Ethinyl Estradiol & Levomefolate Calcium & Levomefolate Calcium Tablets | 3mg/0.02mg/0.451mg and 0.451mg |
|
3 x 28 |
68180-0894-73 |
Beyaz® |
AB |
Oral Contraceptives |
| Duloxetine Hydrochloride DR Capsules USP | 20mg |
 |
30 |
68180-0295-06 |
Cymbalta® |
AB |
Antidepressant |
| Enskyce™ | 0.15 mg /0.03 mg |
|
28 x 3 |
68180-739-73 |
Ortho-Cept® |
AB |
Oral Contraceptives |
| Ethacrynic Acid Tablets | 25mg |
 |
100 |
68180-159-01 |
Edecrin® |
AB |
Diuretic |
| Ethambutol Tablets | 100mg |
 |
100 |
68180-281-01 |
Myambutol® |
AB |
Antimycobacterial agent |
| Famotidine for Oral Suspension | 40mg/5mL |
 |
50mL |
68180-0150-01 |
Pepcid® |
AB |
Histamine H2-Receptor antagonist |
| Fenofibrate Capsules | 43mg |
 |
30 |
68180-0131-06 |
Antara® |
AB |
Antihyperlipidemic |
| Fenofibrate Tablets | 48mg |
 |
90 |
68180-389-09 |
Tricor® |
AB |
Antihyperlipidemic agent |
| Fenofibrate Tablets | 54mg |
 |
90 |
68180-231-09 |
Lofibra® |
AB |
Antihyperlipidemic agent |
| Flucytosine Capsules USP | 250 mg |
 |
100 |
43386-770-01 |
Ancobon® |
AB |
Antifungal |
| Fluocinonide Topical Solution USP | 0.05% |
|
20 mL |
43386-026-06 |
Lidex® |
AT |
Corticosteroid |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-60 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
| Fyavolv™ | 0.5mg/0.0025mg |
|
28 x 3 |
68180-827-73 |
FemHRT® |
AB |
Hormone Replacement Therapy |
| Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
| GaviLAX (PEG3350) Powder for Oral Solution | 17gm/scoopful |
|
238g |
43386-312-08 |
MiraLAX® |
AA |
Laxative |
| GaviLyte™ – C | 240 -5.84-2.98-6.72-22.72gm |
|
4 L |
43386-060-19 |
Colyte® |
AA |
Hyperosmotic |
| GaviLyte™ – G | 236-5.86-2.97-6.74-22.74 gm |
|
4 L |
43386-090-19 |
GoLYTELY® |
AA |
Hyperosmotic |
| GaviLyte™-N | 420-111.20-1.48-5.72 gm |
 |
4 L |
43386-050-19 |
NuLYTELY® |
AA |
Hyperosmotic |
| Hydrocortisone Butyrate Lotion | 0.1% |
|
59 mL |
68180-951-02 |
Locoid® |
AB |
Corticosteroid |
| Hydrocortisone Valerate Cream USP | 0.2% |
|
15 g |
68180-954-02 |
Westcort® |
AB |
Anti-inflammatory |
| Imipramine Pamoate Capsules | 75mg |
 |
30 |
68180-315-06 |
Tofranil-PM® |
AB |
Antidepressant |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
